Oxy-Q may help prevent colon cancer

A pilot clinical trial demonstrates that Oxy-Q, a proprietary pill by Farr Laboratories, LLC that combines the active components of turmeric and onions, reduces both the size and number of precancerous colon polyps.

The unique blend of curcumin, found in turmeric, and quercetin, found in onions and green tea, used in the study can only be found in Oxy-Q.

Five patients, three men and two women ranging in age from 22 to 54, with a genetic form of precancerous lesions in the bowel (familial adenomatous polyposis or FAP) were treated with Oxy-Q over a period of six months. The average number of polyps reduced was 60.4 percent and average size diminished by 50.9 percent. Both the size and the number of polyps were reduced significantly which may indicate that Oxy-Q could help prevent colon cancer in these patients.

"Although small, this is an important study because it provides clinical evidence that a nutritional supplement with curcumin and quercetin, Oxy-Q, may be as effective as pharmaceuticals in this patient population," said Marcia Cruz-Correa, M.D., Ph.D., one of the lead investigators and Assistant Professor of Medicine at Johns Hopkins University School of Medicine and the University of Puerto Rico Comprehensive Cancer Center. "Although both curcumin and quercetin are found in common foods it is very difficult to eat enough to see a therapeutic benefit."

The study was published in the August issue of Clinical Gastroenterology and Hepatology and was funded through a grant from the National Institutes of Health. Researchers who contributed to this study were based at Johns Hopkins University School of Medicine in Baltimore, MD and the Cleveland Clinic Florida in Weston, FL.

http://www.farrlabs.com/